Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy-Reference-Cited by-同舟云学术

Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy

Published:2006-12 Issue:12 Volume:17 Page:1766-1771
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Baz R.,Walker E.,Karam M.A.,Choueiri T.K.,Jawde R.A.,Bruening K.,Reed J.,Faiman B.,Ellis Y.,Brand C.,Srkalovic G.,Andresen S.,Knight R.,Zeldis J.,Hussein M.A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/12/1766/417137/mdl313.pdf

Reference26 articles.

1. Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study;Gertz;Am J Clin Oncol,1995

2. Treatment approaches for relapsing and refractory multiple myeloma;Blade;Acta Oncol,2000

3. A phase 2 study of bortezomib in relapsed, refractory myeloma;Richardson;N Engl J Med,2003

4. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

5. Novel approaches to the management of myeloma;Rajkumar;Oncology (Williston Park),2005

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyethylene glycol-mediated functionalization of nanodelivery systems for improving their pharmacokinetic profile and anticancer efficacy;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-07-30

2. Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an <i>ad hoc</i> expert panel;Haematologica;2022-07-21

3. Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO);Cancers;2021-06-10

4. Venous thromboembolism prophylaxis in patients with multiple myeloma: where are we and where are we going?;Journal of Thrombosis and Thrombolysis;2021-01-08

5. Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine;ACS Omega;2020-10-30